{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:29:28Z","timestamp":1777858168526,"version":"3.51.4"},"reference-count":23,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2003,12]]},"abstract":"<jats:p>Patients with schizophrenia frequently develop drug-induced hyperprolactinaemia and consequent hypogonadism. Reduced bone mineral density as a consequence of hyperprolactinaemia-induced hypogonadism has been well documented in medical, but not psychiatric, disorders. Little attention has been given to the potential risk of developing osteoporosis secondary to anti-psychotic-induced hyperprolactinaemia. Three cases are presented that illustrate how this debilitating but silent disease may affect even those young individuals with schizophrenia.<\/jats:p>","DOI":"10.1177\/0269881103174011","type":"journal-article","created":{"date-parts":[[2004,4,21]],"date-time":"2004-04-21T21:27:18Z","timestamp":1082582838000},"page":"455-458","source":"Crossref","is-referenced-by-count":17,"title":["Reduced Bone Mineral Density in Patients with Schizophrenia Receiving                 Prolactin Raising Anti-Psychotic Medication"],"prefix":"10.1177","volume":"17","author":[{"given":"Anna Maria","family":"Meaney","sequence":"first","affiliation":[{"name":"Waterford Regional Hospital, Waterford, Ireland, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"O\u2019Keane","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, De Crespigny Park, Denmark Hill, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2003,12,1]]},"reference":[{"key":"atypb1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(95)00062-L"},{"key":"atypb2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1998.3691182.x"},{"key":"atypb3","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-68-3-548"},{"key":"atypb4","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199604000-00008"},{"key":"atypb5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1994.tb02788.x"},{"key":"atypb6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1992.tb01473.x"},{"key":"atypb7","volume-title":"American Psychiatric Association","author":"Crawford A M"},{"key":"atypb8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1995.tb00544.x"},{"key":"atypb9","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(89)90119-4"},{"issue":"3","key":"atypb10","first-page":"10","volume":"61","author":"Dickson R","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"atypb11","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(91)90088-3"},{"key":"atypb12","doi-asserted-by":"publisher","DOI":"10.1177\/026988110101500408"},{"key":"atypb13","doi-asserted-by":"publisher","DOI":"10.1097\/00006842-199509000-00011"},{"key":"atypb14","doi-asserted-by":"publisher","DOI":"10.1080\/13651500050518505"},{"key":"atypb15","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.11.1691"},{"key":"atypb16","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-73-1-118"},{"key":"atypb17","first-page":"851","volume":"11","author":"Marken P A","year":"1992","journal-title":"Clin Pharm"},{"key":"atypb18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1986.03380030087034"},{"key":"atypb19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1532-5415.2001.49149.x"},{"key":"atypb20","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.11.1691"},{"key":"atypb21","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.1.133"},{"key":"atypb22","first-page":"6","volume":"843","author":"WHO Study Group","year":"1994","journal-title":"WHO Technical Report Services"},{"key":"atypb23","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(97)81900-0"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0269881103174011","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0269881103174011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:08:49Z","timestamp":1777507729000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0269881103174011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["10.1177\/0269881103174011"],"URL":"https:\/\/doi.org\/10.1177\/0269881103174011","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}